Sweden’s Strategy to Curb Antimicrobial Resistance 2026–2035.

Sweden’s Strategy to Curb Antimicrobial Resistance 2026–2035 sets out a long-term, cross-sectoral plan to address antimicrobial resistance (AMR), particularly antibiotic resistance, which it identifies as a major threat to health, food production, and societal security. Grounded in a One Health approach—recognising the interconnection between humans, animals, and the environment—the Strategy aligns Sweden’s efforts with international commitments under the UN, EU, and Nordic frameworks. Its vision is to maintain access to effective antimicrobial treatments by preventing infections and limiting the development and spread of resistant microorganisms. The Strategy establishes measurable objectives up to 2030 and 2035, including stabilising or reducing key resistant infections (such as MRSA and ESBL), decreasing overall antibiotic use in humans, maintaining low use in animals, reducing healthcare-associated infections, safeguarding vaccine coverage, and ensuring reliable access to effective antibiotics and diagnostics.
To achieve this, the Strategy is structured around ten target areas, including strengthened cross-sector coordination, public communication and behavioural change, global leadership, robust surveillance systems, responsible antibiotic use, infection prevention, environmental protection, access to medicines, and research and innovation. It emphasises strong governance structures (such as Strama), improved data collection and reporting, harmonised treatment guidelines, enhanced healthcare hygiene, and digital monitoring tools. Internationally, Sweden commits to proactive engagement in global AMR initiatives, capacity-building in low- and middle-income countries, and advocacy for sustainable animal husbandry practices. Overall, the Strategy combines domestic public health measures with international cooperation to sustain Sweden’s comparatively favourable AMR situation while contributing to global efforts.